Diffusion Magnetic Resonance Imaging Phenotypes Predict Overall Survival Benefit From Bevacizumab or Surgery in Recurrent Glioblastoma With Large Tumor Burden

Published in Neurosurgery, 2020

Recommended citation: K. Patel, R. Everson, J. Yao, C. Raymond, J. Goldman, J. Schlossman, J. Tsung, C. Tan, W. Pope, M. Ji, N. Nguyen, A. Lai, P. Nghiemphu, L. Liau, T. Cloughesy, B. Ellingson, "Diffusion Magnetic Resonance Imaging Phenotypes Predict Overall Survival Benefit From Bevacizumab or Surgery in Recurrent Glioblastoma With Large Tumor Burden." Neurosurgery, 2020.